Trilogy Metals Inc. (TSX:TMQ)

bluebird bio Income Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Cost of Revenue	-	-	-	-	-	2.61
Gross Profit	-	-	-	-	-	-2.61
Selling, General & Admin	7.46	6.59	7.04	6.7	7.81	8.87
Operating Expenses	7.5	6.63	7.09	6.85	7.98	8.96
Operating Income	-7.5	-6.63	-7.09	-6.85	-7.98	-11.57
Interest & Investment Income	1.07	0.69	0.12	0.03	0.02	0.09
Earnings From Equity Investments	-2.59	-2.64	-7.84	-17.36	-13.08	-2.86
Currency Exchange Gain (Loss)	0.01	0	-0.01	0.02	-0.04	-0.06
Other Non Operating Income (Expenses)	-0.02	-0.01	-0.13	-0.18	-0.58	0.39
EBT Excluding Unusual Items	-9.03	-8.59	-14.95	-24.34	-21.66	-14
Gain (Loss) on Sale of Assets	-	-	-	0.08	-	175.77
Pretax Income	-9.03	-8.59	-14.95	-24.26	-21.66	161.77
Earnings From Continuing Operations	-9.03	-8.59	-14.95	-24.26	-21.66	161.77
Net Income	-9.03	-8.59	-14.95	-24.26	-21.66	161.77
Net Income to Common	-9.03	-8.59	-14.95	-24.26	-21.66	161.77
Shares Outstanding (Basic)	162	160	153	146	144	141
Shares Outstanding (Diluted)	162	160	153	146	144	145
Shares Change (YoY)	3.05%	4.71%	4.75%	0.90%	-0.12%	6.94%
EPS (Basic)	-0.06	-0.05	-0.10	-0.17	-0.15	1.14
EPS (Diluted)	-0.06	-0.05	-0.10	-0.17	-0.15	1.12
Free Cash Flow	-2.18	-1.83	-3.09	-3.94	-5.12	-8.25
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.03	-0.04	-0.06
EBITDA	-7.49	-6.62	-7.08	-6.74	-7.96	-11.48
D&A For EBITDA	0	0	0.01	0.11	0.02	0.09
EBIT	-7.5	-6.63	-7.09	-6.85	-7.98	-11.57

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.